389 related articles for article (PubMed ID: 18204087)
1. The difference between lupus nephritis class IV-G and IV-S in Koreans: focus on the response to cyclophosphamide induction treatment.
Kim YG; Kim HW; Cho YM; Oh JS; Nah SS; Lee CK; Yoo B
Rheumatology (Oxford); 2008 Mar; 47(3):311-4. PubMed ID: 18204087
[TBL] [Abstract][Full Text] [Related]
2. The prognosis and pathogenesis of severe lupus glomerulonephritis.
Schwartz MM; Korbet SM; Lewis EJ;
Nephrol Dial Transplant; 2008 Apr; 23(4):1298-306. PubMed ID: 18045825
[TBL] [Abstract][Full Text] [Related]
3. Revised classification of lupus nephritis is valuable in predicting renal outcome with an indication of the proportion of glomeruli affected by chronic lesions.
Hiramatsu N; Kuroiwa T; Ikeuchi H; Maeshima A; Kaneko Y; Hiromura K; Ueki K; Nojima Y
Rheumatology (Oxford); 2008 May; 47(5):702-7. PubMed ID: 18390590
[TBL] [Abstract][Full Text] [Related]
4. Clinical, biochemical and pathological predictors of poor response to intravenous cyclophosphamide in patients with proliferative lupus nephritis.
Conlon PJ; Fischer CA; Levesque MC; Smith SR; St Clair EW; Allen NB; Fleming JA; Howell DN
Clin Nephrol; 1996 Sep; 46(3):170-5. PubMed ID: 8879851
[TBL] [Abstract][Full Text] [Related]
5. [Comparison of various cyclophosphamide treatment regimens on the course and outcome of lupus nephritis ].
Petrović R; Stojanović R; Novicić-Sasić D; Dimitrijević J; Pavlović S; Stojković D; Palić-Obradović D; Stevanović G; Prodanović S
Srp Arh Celok Lek; 2002 Aug; 130 Suppl 3():19-25. PubMed ID: 12583309
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of diffuse proliferative lupus glomerulonephritis treated with cyclophosphamide.
Mok CC; Ying KY; Ng WL; Lee KW; To CH; Lau CS; Wong RW; Au TC
Am J Med; 2006 Apr; 119(4):355.e25-33. PubMed ID: 16564783
[TBL] [Abstract][Full Text] [Related]
7. Long-term efficacy and safety of quadruple therapy in childhood diffuse proliferative lupus nephritis.
Demircin G; Oner A; Erdoğan O; Delibaş A; Baysun S; Bülbül M; Bek K; Oksal A
Ren Fail; 2008; 30(6):603-9. PubMed ID: 18661410
[TBL] [Abstract][Full Text] [Related]
8. Pulse cyclophospamide in severe lupus nephritis: Southern Indian experience.
Das U; Dakshina Murty KV; Prasad N; Prayag A
Saudi J Kidney Dis Transpl; 2010 Mar; 21(2):372-8. PubMed ID: 20228536
[TBL] [Abstract][Full Text] [Related]
9. Treatment of diffuse proliferative lupus glomerulonephritis: a comparison of two cyclophosphamide-containing regimens.
Mok CC; Ho CT; Siu YP; Chan KW; Kwan TH; Lau CS; Wong RW; Au TC
Am J Kidney Dis; 2001 Aug; 38(2):256-64. PubMed ID: 11479150
[TBL] [Abstract][Full Text] [Related]
10. [Intermittent intravenous administration of cyclophosphamide in patients with lupus nephritis].
Morović-Vergles J; Galesić K; Dancuo I; Vergles D
Acta Med Croatica; 2004; 58(1):13-7. PubMed ID: 15125388
[TBL] [Abstract][Full Text] [Related]
11. Immunosuppressive therapy in lupus nephritis: the Euro-Lupus Nephritis Trial, a randomized trial of low-dose versus high-dose intravenous cyclophosphamide.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; Garrido Ed Ede R; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2002 Aug; 46(8):2121-31. PubMed ID: 12209517
[TBL] [Abstract][Full Text] [Related]
12. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
13. Early response to immunosuppressive therapy predicts good renal outcome in lupus nephritis: lessons from long-term followup of patients in the Euro-Lupus Nephritis Trial.
Houssiau FA; Vasconcelos C; D'Cruz D; Sebastiani GD; de Ramon Garrido E; Danieli MG; Abramovicz D; Blockmans D; Mathieu A; Direskeneli H; Galeazzi M; Gül A; Levy Y; Petera P; Popovic R; Petrovic R; Sinico RA; Cattaneo R; Font J; Depresseux G; Cosyns JP; Cervera R
Arthritis Rheum; 2004 Dec; 50(12):3934-40. PubMed ID: 15593207
[TBL] [Abstract][Full Text] [Related]
14. Treatment and renal outcome of lupus nephritis: single center experience.
Go KW; Teo SM
Med J Malaysia; 2006 Oct; 61(4):447-50. PubMed ID: 17243522
[TBL] [Abstract][Full Text] [Related]
15. Treatment with cyclophosphamide delays the progression of chronic lesions more effectively than does treatment with azathioprine plus methylprednisolone in patients with proliferative lupus nephritis.
Grootscholten C; Bajema IM; Florquin S; Steenbergen EJ; Peutz-Kootstra CJ; Goldschmeding R; Bijl M; Hagen EC; Van Houwelingen HC; Derksen RH; Berden JH;
Arthritis Rheum; 2007 Mar; 56(3):924-37. PubMed ID: 17328070
[TBL] [Abstract][Full Text] [Related]
16. Intravenous pulse cyclophosphamide treatment of severe lupus nephritis: a prospective five-year study.
Valeri A; Radhakrishnan J; Estes D; D'Agati V; Kopelman R; Pernis A; Flis R; Pirani C; Appel GB
Clin Nephrol; 1994 Aug; 42(2):71-8. PubMed ID: 7955581
[TBL] [Abstract][Full Text] [Related]
17. Class V lupus nephritis: a clinicopathologic study in 152 patients.
Chen Q; Liu Z; Hu W; Chen H; Zeng C; Li L
J Nephrol; 2003; 16(1):126-32. PubMed ID: 12653107
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus versus cyclophosphamide as treatment for diffuse proliferative or membranous lupus nephritis: a non-randomized prospective cohort study.
Wang S; Li X; Qu L; Wang R; Chen Y; Li Q; He X; Zhang X; Wang H; Wu J; Xu Y; Chen J
Lupus; 2012 Aug; 21(9):1025-35. PubMed ID: 22570338
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of proliferative lupus nephritis subsets in the Louvain Lupus Nephritis inception Cohort.
Vandepapelière J; Aydin S; Cosyns JP; Depresseux G; Jadoul M; Houssiau FA
Lupus; 2014 Feb; 23(2):159-65. PubMed ID: 24300780
[TBL] [Abstract][Full Text] [Related]
20. Complete remission of lupus nephritis with rituximab and steroids for induction and rituximab alone for maintenance therapy.
Camous L; Melander C; Vallet M; Squalli T; Knebelmann B; Noël LH; Fakhouri F
Am J Kidney Dis; 2008 Aug; 52(2):346-52. PubMed ID: 18572292
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
